The third-generation PDPN-redirected CAR-Ts were reported to mediate efficient anti-tumor responses against PDPN-positive GBM cell lines (LN319, U87MG) in vitro and inhibit r growth in a glioma mouse xenograft model [366]. This evidence concerns the gene PDPN and central nervous system cancer.